These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 26656145)
1. Elevated Lipoprotein(a) Levels, LPA Risk Genotypes, and Increased Risk of Heart Failure in the General Population. Kamstrup PR; Nordestgaard BG JACC Heart Fail; 2016 Jan; 4(1):78-87. PubMed ID: 26656145 [TBL] [Abstract][Full Text] [Related]
2. Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population. Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG J Am Coll Cardiol; 2014 Feb; 63(5):470-7. PubMed ID: 24161338 [TBL] [Abstract][Full Text] [Related]
3. Elevated Lipoprotein(a) Does Not Cause Low-Grade Inflammation Despite Causal Association With Aortic Valve Stenosis and Myocardial Infarction: A Study of 100,578 Individuals from the General Population. Langsted A; Varbo A; Kamstrup PR; Nordestgaard BG J Clin Endocrinol Metab; 2015 Jul; 100(7):2690-9. PubMed ID: 25938632 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) concentrations, isoform size, and risk of type 2 diabetes: a Mendelian randomisation study. Kamstrup PR; Nordestgaard BG Lancet Diabetes Endocrinol; 2013 Nov; 1(3):220-7. PubMed ID: 24622370 [TBL] [Abstract][Full Text] [Related]
8. Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population: the Copenhagen City Heart Study. Kamstrup PR; Benn M; Tybjaerg-Hansen A; Nordestgaard BG Circulation; 2008 Jan; 117(2):176-84. PubMed ID: 18086931 [TBL] [Abstract][Full Text] [Related]
9. No evidence that genetically reduced 25-hydroxyvitamin D is associated with increased risk of ischaemic heart disease or myocardial infarction: a Mendelian randomization study. Brøndum-Jacobsen P; Benn M; Afzal S; Nordestgaard BG Int J Epidemiol; 2015 Apr; 44(2):651-61. PubMed ID: 25981321 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) levels, genotype, and incident aortic valve stenosis: a prospective Mendelian randomization study and replication in a case-control cohort. Arsenault BJ; Boekholdt SM; Dubé MP; Rhéaume E; Wareham NJ; Khaw KT; Sandhu MS; Tardif JC Circ Cardiovasc Genet; 2014 Jun; 7(3):304-10. PubMed ID: 24704946 [TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin levels and risk of heart failure, atrial fibrillation, aortic valve stenosis, and myocardial infarction: large-scale observational and Mendelian randomization evidence. Nielsen MB; Çolak Y; Benn M; Mason A; Burgess S; Nordestgaard BG Cardiovasc Res; 2024 Feb; 120(1):95-107. PubMed ID: 37897683 [TBL] [Abstract][Full Text] [Related]
13. Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records. Chen HY; Dufresne L; Burr H; Ambikkumar A; Yasui N; Luk K; Ranatunga DK; Whitmer RA; Lathrop M; Engert JC; Thanassoulis G JAMA Cardiol; 2018 Jan; 3(1):18-23. PubMed ID: 29128868 [TBL] [Abstract][Full Text] [Related]
14. Effect of APOE ε Genotype on Lipoprotein(a) and the Associated Risk of Myocardial Infarction and Aortic Valve Stenosis. Kritharides L; Nordestgaard BG; Tybjærg-Hansen A; Kamstrup PR; Afzal S J Clin Endocrinol Metab; 2017 Sep; 102(9):3390-3399. PubMed ID: 28651346 [TBL] [Abstract][Full Text] [Related]
15. Elevated Lipoprotein(a) and Risk of Ischemic Stroke. Langsted A; Nordestgaard BG; Kamstrup PR J Am Coll Cardiol; 2019 Jul; 74(1):54-66. PubMed ID: 31272552 [TBL] [Abstract][Full Text] [Related]
16. Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals. Dalila N; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A Atherosclerosis; 2023 Jul; 376():26-33. PubMed ID: 37263031 [TBL] [Abstract][Full Text] [Related]